Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion
Vertex Pharmaceuticals will buy Alpine Immune Sciences for about $4.9 billion in cash, gaining access to a treatment for an autoimmune disease of the kidney.
Source: cnbc.com
Page 19 - Alpine Immune Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Alpine Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Alpine Immune Sciences Today - Breaking & Trending Today
Stock futures slip on Wednesday evening as traders brace for another inflation report: Live updates
The S&P 500 rose Thursday as Wall Street digested fresh inflation data.
Source: nbcdfw.com
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal
Vertex Pharmaceuticals will pay $4.9 billion to acquire Alpine Immune Sciences. Alpine stock rocketed. . ...
Source: wn.com
Stock futures slip on Wednesday evening as traders brace for another inflation report: Live updates
The S&P 500 rose Thursday as Wall Street digested fresh inflation data.
Source: nbcchicago.com
Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion
Vertex Pharmaceuticals has agreed to acquire Alpine Immune Sciences for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in…
Source: biztoc.com